Day 1 of the 11th Annual Clinical Trials in Oncology Europe 2024! Connect with Alessandro Leggio, Business Development Manager at #OPIS, who is on-site and ready to discuss how OPIS can support your oncology clinical trials. Whether you are looking to explore new opportunities or enhance your current trials, Alessandro is here to offer expert guidance and tailored solutions to help advance your oncology research. Don’t miss the opportunity to connect and discover how we can support the success of your oncology projects. #CTOEU24 #OPIS #OncologyResearch #ClinicalTrials #ClinicalDevelopment
OPIS
Servizi di ricerca
Desio, Monza Brianza 68.485 follower
A Science Driven Biotech Focused CRO
Chi siamo
OPIS was founded in 1998 by medical doctors from the Pharma Industry and is a Global clinical CRO with 26 years of experience in a wide range of therapeutic areas. OPIS provides full-service, 360° clinical trial support from study concept creation and protocol development to full project execution, study data handling and up to study closure, analysis, and reporting. We manage Phase I-IV, interventional, non-interventional and medical devices studies on an international level. In addition, OPIS also manages pre- and post-marketing clinical investigations for medical and diagnostic devices, nutraceutical, and food supplement studies. Our qualified, fully trained, and dedicated staff has managed more than 1500 studies. OPIS’s strength lies in its people and its specialized teams who assist clients from A-Z with medical writing, scientific and statistical consultancy for trial design and skilled teams of operational staff that ensure high quality project execution, with global coverage. Our mission is to increase the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages local regulatory and deep therapeutic expertise across all major areas including oncology, cardiology, dermatology, endocrinology, gastroenterology, gene therapy, hematology, genetic diseases, hepatology, immunology, infectious diseases, musculoskeletal, dietary supplements, metabolism and nutrition disorders, nephrology, neurology, onco-hematology, ophthalmology, respiratory diseases, rare diseases, urogenital disorders and vaccines. OPIS is committed to continuous growth and expansion, while currently we have affiliates in 18 countries around the world. For more information, visit www.opisresearch.com For Employment and Careers, visit www.opisresearch.com/opis-career/
- Sito Web
-
www.opisresearch.com
Link esterno per OPIS
- Settore
- Servizi di ricerca
- Dimensioni dell’azienda
- 201-500 dipendenti
- Sede principale
- Desio, Monza Brianza
- Tipo
- Società privata non quotata
- Data di fondazione
- 1998
- Settori di competenza
- Clinical Research, CRO, Clinical Development, Early phase trials, Post market studies, Observational research, Real world evidence studies, investigator initiated trials, medical device clinical investigations, nutraceutical studies, medical affairs and medical writing, Regulatory, Trials Start-Up, Data Management, Pharmacovigilance, Quality Assurance, e-Clinical Platform, Project Control, Statistical Analysis and Consultancy, Staudy Management and Monitoring, Preclinical and Drug Development Consultancy, Medical Monitoring, Medical Feasibility e Other Services
Località
Dipendenti presso OPIS
Aggiornamenti
-
Join #OPIS at Biotech Showcase 2025 in San Francisco! We are excited to announce our participation in Biotech Showcase, taking place from January 13-15 in San Francisco, CA. Our team of experts will be on-site, ready to discuss how OPIS’s comprehensive clinical trial solutions can support your drug development journey. From early-stage trials to complex late-phase projects, we are here to help you achieve your goals with efficiency and expertise. Let’s connect! Schedule a meeting with us on the event’s partnering platform, or visit opisresearch.com to learn more about how OPIS can add value to your clinical research programs. #BiotechShowcase #ClinicalExcellence #ClinicalTrials #BiotechInnovation
-
-
Join #OPIS at the 11th Annual Clinical Trials in Oncology Europe 2024! We are excited to be part of the upcoming Annual Clinical Trials in Oncology Europe this December. Our experts Alessandro Leggio (Business Development Manager) and Faisal Zaman (Director of Clinical Development) will be on-site, ready to discuss how OPIS’s extensive experience and innovative solutions can support the unique challenges of oncology studies—from early-stage trials to complex late-phase projects. Don’t miss the chance to connect with Alessandro and Faisal and explore how OPIS can bring value to your oncology projects. Visit opisresearch.com to connect with us directly and start a conversation.
-
-
It is the final day at Bio-Europe 2024, and what a fantastic experience it has been! Over the past few days, we have had the opportunity to connect with leaders in the clinical research and pharmaceutical industries. With OPIS at Booth #167 and Clinical.net at Booth #105, we were proud to showcase our comprehensive solutions, from cutting-edge clinical trial services to operational excellence. Thank you to everyone who visited us! If you didn’t get the chance to meet us at #BioEurope, don’t hesitate to reach out! We look forward to discussing how OPIS and Clinical.net can support your clinical research needs. Visit opisresearch.com or clinical.net to get in touch. #BioEurope2024 #OPIS #Clinical.net
-
-
We are on-site at the KoNECT-MOHW-MFDS International Conference in Seoul, and there are still two days left to connect! Today, SangWoo Kwon (Director of APAC Clinical Operations) delivered a key session on "Building Better Clinical Trials: The Impact of CRO Attributes on Patient Recruitment," sharing insights into how OPIS’s approach enhances recruitment outcomes and trial success. Visit our booth (nr 4-5 | Hanra Hall Lobby) to connect with our team—Changsook Park (Business Development Director), SangWoo Kwon, and Rio Park (Business Development Associate)—and discover how OPIS’s expertise in clinical trials can support your research across the Asia-Pacific region and beyond. Don’t miss the chance to explore innovative solutions and discuss potential collaborations that can drive success for your projects. #OPIS #KoNECT #KoNECT2024 KoNECT (Korea National Enterprise for Clinical Trials)
-
-
Join #OPIS at Bio-Europe 2024! Visit us at booths #167 and #105 to connect with our team of experts, including Giovanni Trolese (VP), Elena Ravasi (Senior Director of Clinical Development), Michele Montanari (ICT Associate Director), Faisal Zaman (Director of Clinical Development), SHIHHUNG CHOU, Alan Syu, Chanelle Becker, and Rio Park from our Business Development team. Whether you are interested in exploring new insights or discussing strategic collaborations, our team is ready to support your clinical development goals and share how OPIS can add value to your projects. We look forward to connecting at Bio-Europe! https://bit.ly/3YwNk8w #BioEurope2024 #BioEurope
-
-
The 16th Annual Outsourcing in Clinical Trials (OCT) New England event, held on October 23-24 in Boston, MA, was a fantastic success! Over the two-day conference, Jim Barrio (Executive Director of Business Development) and Chanelle Backer (Business Development Associate) engaged in insightful discussions with leaders across the biopharma industry. They had the opportunity to showcase our full range of solutions and discuss strategies for advancing clinical trial efficiency and enhancing operations at every stage of development. If you missed the chance to connect with our team or would like to continue the conversation, please don’t hesitate to reach out! https://bit.ly/3YwNk8w #OCTNewEngland #OCTNewEngland2024 Arena International Events Group
-
-
We are proud to share that our Vice President was a featured speaker at the 5th Symposium of Rare Genetic Diseases in Busan! Giovanni's presentation highlighted how clinical research can drive progress in the treatment of rare diseases and showcased OPIS’s commitment to overcoming challenges and delivering success in rare disease studies. A heartfelt thank you to everyone who attended and engaged with us during this inspiring event. If you missed us at the symposium, we invite you to connect with us! Visit www.opisresearch.com to learn more about how #OPIS can support your clinical trials. #RareDiseases #ClinicalTrials #BusanConference
-
-
Celebrating 26 Years of OPIS! Today marks a significant milestone for OPIS – 26 years of growth and achievements! From our humble beginnings to becoming a leader in our industry, we owe our success to our dedicated and passionate team. Thank you to everyone who has been part of this journey! Here are 26 years of teamwork and many more to come! #OPIS #Anniversary #Teamwork #OPISTeam #26yearswithOPIS
-
Join #OPIS at the 2024 KoNECT-MOHW-MFDS International Conference in Seoul, October 29-31! Connect with our experts—SangWoo Kwon, Changsook Park, and Rio Park—to discover how OPIS’s extensive expertise and innovative solutions can elevate your clinical research across the Asia-Pacific region and on a global scale. Whether you need local insights or comprehensive trial management, OPIS is here to drive your clinical development forward. We look forward to meeting you at KIC 2024! Schedule a meeting with us today, and let’s explore how we can help accelerate your success. https://bit.ly/3YwNk8w #KIC2024 #ClinicalResearch #KoNECT #KoNECT24 KoNECT (Korea National Enterprise for Clinical Trials)
-